XOSPATA QUICK START+® Program
The XOSPATA QUICK START+ Program provides a one-time, 7-day supply of XOSPATA® (gilteritinib) at no cost to eligible patients who experience an insurance-related delay.
- To be eligible for the QUICK START+ Program, patients must:
- Have prescription drug insurance,
- Be new to XOSPATA therapy,
- Have been prescribed XOSPATA for an FDA-approved indication, AND
- Have experienced an insurance-related access delay
- Offers overnight shipping directly to the patient
XOSPATA Support Solutions is a component of Astellas Pharma Support SolutionsSM.
QUICK START+® is a registered trademark of Astellas US LLC.